DE69117965D1 - Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper - Google Patents

Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper

Info

Publication number
DE69117965D1
DE69117965D1 DE69117965T DE69117965T DE69117965D1 DE 69117965 D1 DE69117965 D1 DE 69117965D1 DE 69117965 T DE69117965 T DE 69117965T DE 69117965 T DE69117965 T DE 69117965T DE 69117965 D1 DE69117965 D1 DE 69117965D1
Authority
DE
Germany
Prior art keywords
peptides
antibodies
hiv
inducate
targeted against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69117965T
Other languages
English (en)
Other versions
DE69117965T2 (de
Inventor
Luc Montagnier
Danielle Berneman
Denise Guetard
Elmostafa Bahraoui
Rietschoten Jurphaas Van
Solange Chamaret
Alain Blanchard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9013324A external-priority patent/FR2668488A1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of DE69117965D1 publication Critical patent/DE69117965D1/de
Application granted granted Critical
Publication of DE69117965T2 publication Critical patent/DE69117965T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1253—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69117965T 1990-09-27 1991-09-27 Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper Expired - Fee Related DE69117965T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9011951 1990-09-27
FR9013324A FR2668488A1 (fr) 1990-10-26 1990-10-26 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides.
PCT/FR1991/000758 WO1992006199A2 (fr) 1990-09-27 1991-09-27 Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides

Publications (2)

Publication Number Publication Date
DE69117965D1 true DE69117965D1 (de) 1996-04-18
DE69117965T2 DE69117965T2 (de) 1996-11-14

Family

ID=26228256

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69117965T Expired - Fee Related DE69117965T2 (de) 1990-09-27 1991-09-27 Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper

Country Status (8)

Country Link
EP (2) EP0736542A1 (de)
AT (1) ATE135407T1 (de)
CA (1) CA2092546A1 (de)
DE (1) DE69117965T2 (de)
DK (1) DK0550691T3 (de)
ES (1) ES2087311T3 (de)
GR (1) GR3020185T3 (de)
WO (1) WO1992006199A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753502A (en) * 1993-08-05 1998-05-19 Icos Corporation Neuron-specific ICAM-4 promoter
US5773293A (en) * 1992-01-27 1998-06-30 Icos Corporation Anti-ICAM-4 antibodies and hybridomas
US5700658A (en) * 1992-01-27 1997-12-23 Icos Corporation ICAM-4 materials and methods
FR2696186B1 (fr) * 1992-09-28 1994-12-02 Pasteur Institut Souches de Mycoplasma. fermentans cytopathogène et procédés de diagnostic in vitro et d'immunisation mettant en Óoeuvre de telles souches.
FR2705970B1 (fr) * 1993-06-04 1995-08-04 Pasteur Institut Identification du gène de l'adhésine de M. Pirum.
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
CA2391560A1 (en) 1999-11-16 2001-05-25 Geneart Gmbh Gessellschaft Fur Angewandte Biotechnologie The genome of the hiv-1 inter-subtype (c/b') and use thereof
EP2905031A1 (de) * 2014-02-10 2015-08-12 B Cell Design Neues, nicht-HIV-Impfstoff-Antigen aus der vaginalen Mikrobiota zur Induzierung einer mukosalen, neutralisierenden, schützenden Antikörperreaktion gegen eine HIV-Infektion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945041A (en) * 1983-11-17 1990-07-31 Board Of Regents Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia
DE122005000039I1 (de) * 1984-10-18 2006-02-23 Pasteur Institut DNS-Fragmente des GAG-Gens von LAV

Also Published As

Publication number Publication date
CA2092546A1 (fr) 1992-03-28
ATE135407T1 (de) 1996-03-15
GR3020185T3 (en) 1996-09-30
EP0550691B1 (de) 1996-03-13
WO1992006199A3 (fr) 1992-05-29
DE69117965T2 (de) 1996-11-14
DK0550691T3 (da) 1996-07-29
ES2087311T3 (es) 1996-07-16
EP0736542A1 (de) 1996-10-09
EP0550691A1 (de) 1993-07-14
WO1992006199A2 (fr) 1992-04-16

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
LU91166I2 (fr) Enfuvirtide, facultativement sous forme d'un sel ou ester pharmaceutiquement acceptable (FUZEON).
RU2012106150A (ru) Вариантные формы уратоксидазы и их применение
NO20025153D0 (no) FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
MXPA06014393A (es) Peptidos oligomericos y su uso para el tratamiento de infecciones por vih.
DE69117965D1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
ATE403726T1 (de) Cytokin-proteinfamilie
WO2002068608A3 (en) Sulfated ccr5 peptides for hiv-1 infection
DK0579363T3 (da) Behandling af tropisk spastisk parese med peptid T
KR920012114A (ko) 사람 면역결핍 바이러스(HIV)의 그룹-특이 항원(gaa)의 선택된 펩타이드, 이의 제법 및 용도
DK0426314T3 (da) HIV-relaterede peptider
HUP0202653A2 (hu) Autoimmun állapotok kezelése 1-típusú kopolimerrel és rokon kopolimerekkel
RU2009123462A (ru) Гомогенные препараты il-28 и il-29
ECSP003720A (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee